Liabilities / Assets
9th percentile
Higher debt load relative to assets than 9% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
95th percentile
Higher debt load relative to revenue than 95% of similar nonprofits.
Net Margin
1st percentile
Higher net margin than 1% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
27th percentile
Faster asset growth than 27% of similar nonprofits.
Revenue Growth
98th percentile
Faster revenue growth than 98% of similar nonprofits.
Balance Sheet
Assets
Up$55,142,578
Up $262,918 (+0.5%) from 2012
Net Assets
Up$54,497,750
Up $270,616 (+0.5%) from 2012
Liabilities
Down$644,828
Down $7,700 (-1.2%) from 2012
Revenue And Expenses
Revenue
Up$85,332
Up $59,743 (+233%) from 2012
Expenses
Down$467,317
Down $1,693 (-0.4%) from 2012
Net Income
Up-$381,985
Up $61,436 (+14%) from 2012
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Oct 1, 2012 to Sep 30, 2013
Mission and Program Overview
Mission
Advancement of scientific and biomedical research through the discovery of cures for human disease.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $55,142,578
- Liabilities
- $644,828
- Net assets
- $54,497,750
- Revenue
- $85,332
- Expenses
- $467,317
- Net income
- -$381,985